<DOC>
	<DOCNO>NCT00276770</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , positron emission tomography use fluorothymidine F 18 , may effective find recurrent disease patient gliomas . PURPOSE : This clinical trial study well positron emission tomography use fluorothymidine F 18 work find recurrent disease patient gliomas .</brief_summary>
	<brief_title>Positron Emission Tomography Using Fluorothymidine F 18 Finding Recurrent Disease Patients With Gliomas</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine safety fluorothymidine F 18 visual dynamic brain tumor image patient glial neoplasm . - Determine , preliminarily , efficacy drug . Secondary - Compare , preliminarily , efficacy drug fludeoxyglucose F 18 differentiate tumor recurrence radiation necrosis . - Determine optimal time image post injection drug . OUTLINE : This pilot , nonrandomized study . Patients receive fluorothymidine F 18 IV 1 minute undergo positron emission tomography ( PET ) scan brain 2 hour . After completion PET scan , patient follow least 1 month . PROJECTED ACCRUAL : A total 12 patient accrue study .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Radiological establish histological diagnosis glioma WHO grade 24 disease Presence new enlarge enhance lesion gadoliniumenhanced MRI prior radiotherapy Differentiation recurrent tumor radiation necrosis possible No clinically significant sign uncal herniation , include follow : Acute pupillary enlargement Rapidly develop ( i.e. , hour ) motor change Rapidly decrease level consciousness PATIENT CHARACTERISTICS : Platelet count ≥ 75,000/mm^3 WBC ≥ 3,000/mm^3 Gammaglutamyltransferase ≤ 5 time upper limit normal ( ULN ) Absolute neutrophil count ≥ 1,500/mm^3 Hemoglobin ≥ 10 g/dL SGOT SGPT ≤ 2 time ULN Alkaline phosphatase ≤ 2 time ULN Lactic dehydrogenase ≤ 2 time ULN Direct total bilirubin normal Amylase normal Haptoglobin normal Serum electrolytes normal CBC platelet normal PT , PTT normal BUN creatinine normal Not pregnant lactate Urinalysis normal Negative pregnancy test Female patient must postmenopausal ≥ 1 year surgically sterile , 1 follow method birth control ≥ 1 month : IUD , oral contraceptive , DepoProvera , Norplant These criterion waive discretion investigator patient 's intracranial tumor consider life threaten 1month wait require best interest patient No known allergic hypersensitivity reaction previously administer radiopharmaceutical No know HIV positivity Not require monitor anesthesia positron emission tomography scan PRIOR CONCURRENT THERAPY : Concurrent biopsy neurosurgical procedure diagnostic and/or therapeutic purpose cancer allow Concurrent surgery cancer allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult mixed glioma</keyword>
</DOC>